Literature DB >> 14644026

Amyloid-beta peptide-specific single chain Fv antibodies isolated from an immune phage display library.

K Manoutcharian1, G Acero, M E Munguia, J A Montero, T Govezensky, C Cao, K Ugen, G Gevorkian.   

Abstract

A single-chain fragment variable (scFv) antibody library displayed on phage was constructed using spleen cells from mice immunized with human amyloid-beta peptide (Abeta42). This first anti-Abeta42 scFv immune antibody library was selected against human Abeta42. A number of positive clones were obtained, and sequences of VH and Vkappa genes were analyzed using ExPASy and BLAST computer tools. This analysis revealed that only two unique clones with identical VH and Vkappa complementarity determining region (CDR) (except HCDR2) and identical germline genes were selected, indicating that oligoclonal immune response was occurring in Abeta42-immunized mice. Abeta42-specific scFv antibodies selected from this first immune anti-Abeta42 phage antibody library may be an important tool for the development of therapeutic molecules for Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644026     DOI: 10.1016/j.jneuroim.2003.08.038

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries.

Authors:  M Medecigo; K Manoutcharian; V Vasilevko; T Govezensky; M E Munguia; B Becerril; A Luz-Madrigal; L Vaca; D H Cribbs; G Gevorkian
Journal:  J Neuroimmunol       Date:  2010-05-06       Impact factor: 3.478

2.  Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B).

Authors:  Goar Gevorkian; Alfonso Gonzalez-Noriega; Gonzalo Acero; Jorge Ordoñez; Colette Michalak; Maria Elena Munguia; Tzipe Govezensky; David H Cribbs; Karen Manoutcharian
Journal:  Neurochem Int       Date:  2007-11-12       Impact factor: 3.921

3.  Short Peptides as Inhibitors of Amyloid Aggregation.

Authors:  Bradley Neddenriep; Anastasia Calciano; Daniel Conti; Erin Sauve; Marissa Paterson; Edward Bruno; David A Moffet
Journal:  Open Biotechnol J       Date:  2011-12-23

Review 4.  Recombinant Antibody Fragments for Neurodegenerative Diseases.

Authors:  Karen Manoutcharian; Roxanna Perez-Garmendia; Goar Gevorkian
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.